UK expansion validated with market insights
TALi Health is an EdTech/HealthTech venture that tackles the growing challenges of clinical attention deficits symptomatic of ADHD and Autism Spectrum Disorders. The platform is currently being used by schools and healthcare professionals across Australia, the US and Singapore, with the UK being their next destination.
TALi creates game-based programs to assess and improve attention in young children aged 3-8. Its ground-breaking technology, based on 25 years of clinical research, includes the TALi Detect Digital Attention Assessment tool to flag children that require support and the TALi Train digital training program that has been clinically validated to boost attention in children in just 5 weeks.
Newfound worked closely with Alex Barty who heads up international partnerships at TALi to provide in-depth market analysis to help validate and pinpoint UK market opportunities.
Newfound has done exceptional work in giving us insights on the market opportunity for a digital intervention like ours. The report was enormously beneficial and will craft the way that we enter the market.
In under 6 weeks, Newfound delivered key insights on market trends, the size of the UK opportunity, potential routes to market, and a comprehensive list of key partner organisations through its Go-No-Go market validation report. The report gave TALi the confidence to plan for UK market entry and act as a guide for their go-to-market strategy.
In addition, Newfound arranged a curated schedule of UK experts for Alex to meet with, including partners and advisors, in the EdTech and HealthTech industries during his UK market visit in January 2020.